Mankind Pharma Ltd Quarterly Results

Gross Sales

3,079.37

3,198.79

3,076.51

2,893.42

2,422.24

Excise Duty

0

0

0

0

0

Net Sales

3,079.37

3,198.79

3,076.51

2,893.42

2,422.24

Other Operating Income

0

0

0

0

0

Other Income

253.65

87.09

112

104.51

94.56

Total Income

3,333.02

3,285.88

3,188.51

2,997.93

2,516.8

Total Expenditure

2,400.52

2,382.8

2,226.47

2,211.66

1,836.27

PBIDT

932.5

903.08

962.04

786.27

680.53

Interest

190.54

220.93

7.1

10.91

9.17

PBDT

741.96

682.15

954.94

775.36

671.36

Depreciation

230.87

187.17

105.62

107.74

99.78

Minority Interest Before NP

0

0

0

0

0

Tax

131.51

157.76

168.13

138.7

114.45

Deferred Tax

-45.07

-47.3

22.31

-14.15

-19.46

Reported Profit After Tax

424.65

384.52

658.88

543.07

476.59

Minority Interest After NP

3.88

4.29

5.41

6.58

5.35

Net Profit after Minority Interest

420.77

380.23

653.47

536.49

471.24

Extra-ordinary Items

-4.34

6.65

0

0

-0.33

Adjusted Profit After Extra-ordinary item

425.11

373.58

653.47

536.49

471.57

EPS (Unit Curr.)

10.19

9.46

16.31

13.39

11.76

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

41.26

40.06

40.06

40.06

40.06

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

30.28

28.23

31.27

27.17

28.09

PBDTM(%)

24.09

21.32

31.03

26.79

27.71

PATM(%)

13.79

12.02

21.41

18.76

19.67